BDBM50010156 3-[1-carbamoyl-2-hydroxy-(1S)-ethylcarbamoyl]-3-[2-(citrulline)-1-methylcarboxamido-carboxamidomethylcarboxamido]propanoic acid::CHEMBL2370391
SMILES: CC(=O)N[C@@H](CCCNC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(N)=O
InChI Key: InChIKey=GSBVIJRIXWULDX-DCAQKATOSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50010156![]() (3-[1-carbamoyl-2-hydroxy-(1S)-ethylcarbamoyl]-3-[2...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet ![]() | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >2.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Research and Development Curated by ChEMBL | Assay Description Inhibition of canine platelet-rich plasma agregation induced by ADP | J Med Chem 34: 3114-25 (1991) BindingDB Entry DOI: 10.7270/Q2445KF0 | |||||||||||
More data for this Ligand-Target Pair |